...

Sublocade Treatment

Monthly Buprenorphine Injections for Opioid Recovery in Orange County, California

Steady medication, steady recovery. At Addiction Recovery Center, our Orange County facility provides Sublocade treatment for adults aged 18 and older seeking help for opioid addiction. Sublocade is an FDA-approved monthly injection that delivers extended-release buprenorphine, providing consistent medication levels that eliminate daily dosing while maintaining the proven benefits of buprenorphine therapy.

For individuals already stable on daily buprenorphine (Suboxone), Sublocade offers a significant upgrade: one injection per month replaces daily medication, removing the burden of daily dosing, reducing diversion potential, and providing smoother, more consistent relief from cravings. The extended-release formulation maintains steady medication levels without the peaks and troughs that can occur with daily dosing.

Sublocade is part of our comprehensive Medication-Assisted Treatment (MAT) program at Addiction Recovery Center. Our medical team evaluates whether Sublocade is appropriate for your situation – typically for those who have achieved stability on daily buprenorphine and are ready to transition to monthly injections. Same-day assessments are available when you are ready to explore this option.

Contact Addiction Recovery Center at (866) 502-4344 or visit our Contact Us page for a free, confidential assessment to begin your journey toward recovery and renewed hope.

Read More Show Less
Understanding Sublocade

What Is Sublocade?

Sublocade is the brand name for extended-release buprenorphine, an injectable medication administered once monthly for the treatment of moderate to severe opioid use disorder. Buprenorphine is a partial opioid agonist – it activates opioid receptors enough to prevent withdrawal and reduce cravings without producing significant euphoria or impairment at therapeutic doses.

Sublocade vs. Other MAT Medications

Factor

Sublocade

Suboxone

Vivitrol

Medication Type

Partial opioid agonist

Partial opioid agonist

Opioid antagonist (blocker)

Active Ingredient

Buprenorphine

Buprenorphine/naloxone

Naltrexone

Administration

Monthly subcutaneous injection

Daily sublingual film/tablet

Monthly intramuscular injection

Requires Prior Buprenorphine

Yes (must be stable on daily buprenorphine first)

No (can initiate directly)

No

Prevents Withdrawal

Yes

Yes

No (requires completed detox)

Blocks Other Opioids

Partially

Partially

Completely

Sublocade vs. Other MAT Medications

Factor Sublocade Suboxone Vivitrol
Medication Type Partial opioid agonist Partial opioid agonist Opioid antagonist (blocker)
Active Ingredient Buprenorphine Buprenorphine/naloxone Naltrexone
Administration Monthly subcutaneous injection Daily sublingual film/tablet Monthly intramuscular injection
Requires Prior Buprenorphine Yes (must be stable on daily buprenorphine first) No (can initiate directly) No
Prevents Withdrawal Yes Yes No (requires completed detox)
Blocks Other Opioids Partially Partially Completely

Why Sublocade Matters

Sublocade offers distinct advantages for individuals in opioid addiction recovery. Sublocade matters because it provides:
  • Consistent buprenorphine levels without daily dosing variability
  • Monthly administration eliminating daily medication routines
  • Reduced diversion risk compared to take-home buprenorphine
  • Elimination of daily decisions about medication compliance
  • Smoother experience without between-dose fluctuations
  • Simplified transition through levels of care
Read More Show Less

Why Sublocade Matters

Sublocade offers distinct advantages for individuals in opioid addiction recovery. Sublocade matters because it provides:

  • Consistent buprenorphine levels without daily dosing variability
  • Monthly administration eliminating daily medication routines
  • Reduced diversion risk compared to take-home buprenorphine
  • Elimination of daily decisions about medication compliance
  • Smoother experience without between-dose fluctuations
  • Simplified transition through levels of care
Our Approaches

Our Sublocade Treatment Approach

Addiction Recovery Center delivers Sublocade treatment within a comprehensive care model, ensuring medication is supported by the therapeutic interventions necessary for sustained recovery.

Transition Assessment

Sublocade requires prior stability on daily buprenorphine. Our medical team evaluates readiness for transition.

Assessment Component

What We Evaluate

Why It Matters

Buprenorphine Stability

Minimum 7 days on stable daily dose (8-24mg)

Ensures therapeutic baseline before conversion

Dose Optimization

Current buprenorphine dose adequacy

Confirms dosing appropriate for Sublocade transition

Treatment Engagement

Participation in therapy, appointment attendance

Indicates readiness for monthly injection format

Diversion Risk

History of medication misuse or diversion

Sublocade eliminates take-home diversion concerns

Injection Preference

Comfort with monthly injection versus daily medication

Confirms Sublocade aligns with preferences

 

Transition Assessment

Sublocade requires prior stability on daily buprenorphine. Our medical team evaluates readiness for transition.

Assessment ComponentWhat We EvaluateWhy It Matters
Buprenorphine StabilityMinimum 7 days on stable daily dose (8-24mg)Ensures therapeutic baseline before conversion
Dose OptimizationCurrent buprenorphine dose adequacyConfirms dosing appropriate for Sublocade transition
Treatment EngagementParticipation in therapy, appointment attendanceIndicates readiness for monthly injection format
Diversion RiskHistory of medication misuse or diversionSublocade eliminates take-home diversion concerns
Injection PreferenceComfort with monthly injection versus daily medicationConfirms Sublocade aligns with preferences

Injection Protocol

Sublocade administration follows precise medical protocols:

  • Subcutaneous injection administered in the abdominal area
  • Rotating injection sites with each monthly dose
  • Initial loading doses (300mg) for the first two months typically
  • Maintenance doses (100mg or 300mg) based on individual needs
  • Administered only by certified healthcare providers at our facility
  • Brief observation period following injection

Ongoing Management

Throughout Sublocade treatment, we provide continuous medical support:

  • Monthly appointments for injection and assessment
  • Monitoring of medication effectiveness and side effects
  • Dose adjustments based on clinical response
  • Coordination with therapy and counseling programming
  • Management of any injection site reactions
  • Long-term treatment planning and eventual transition discussions
Read More Show Less

Injection Protocol

Sublocade administration follows precise medical protocols:

  • Subcutaneous injection administered in the abdominal area
  • Rotating injection sites with each monthly dose
  • Initial loading doses (300mg) for the first two months typically
  • Maintenance doses (100mg or 300mg) based on individual needs
  • Administered only by certified healthcare providers at our facility
  • Brief observation period following injection

Ongoing Monitoring

Throughout Sublocade treatment, we provide continuous medical support:

  • Monthly appointments for injection and assessment
  • Monitoring of medication effectiveness and side effects
  • Dose adjustments based on clinical response
  • Coordination with therapy and counseling programming
  • Management of any injection site reactions
  • Long-term treatment planning and eventual transition discussions
Sublocade for Specific Opioid Addictions

Sublocade for Specific Opioid Addictions

Sublocade treats opioid use disorder regardless of the specific opioid involved. Our clinical team tailors the approach based on your history and needs.

How Sublocade Applies to Different Addictions

Condition

Sublocade Approach

Heroin Addiction Treatment

Transition from daily buprenorphine once stable; consistent monthly levels prevent breakthrough cravings common with daily dosing variability

Fentanyl Addiction Treatment

May require higher maintenance doses (300mg) due to fentanyl potency; extended-release format provides reliable coverage for potent synthetic opioids

Prescription Opioid Addiction

Effective for those transitioning from prescription painkiller dependence; eliminates daily medication that may feel similar to previous pills

Chronic Relapse Prevention

Monthly injection removes daily adherence challenges that contribute to relapse; medication continues working regardless of motivation fluctuations

Treatment Transition Support

Simplifies progression through Residential Treatment, IOP, and Addiction Aftercare Services with consistent monthly dosing

How Sublocade Applies to Different Addictions

ConditionSublocade Approach
Heroin Addiction TreatmentTransition from daily buprenorphine once stable; consistent monthly levels prevent breakthrough cravings common with daily dosing variability
Fentanyl Addiction TreatmentMay require higher maintenance doses (300mg) due to fentanyl potency; extended-release format provides reliable coverage for potent synthetic opioids
Prescription Opioid AddictionEffective for those transitioning from prescription painkiller dependence; eliminates daily medication that may feel similar to previous pills
Chronic Relapse PreventionMonthly injection removes daily adherence challenges that contribute to relapse; medication continues working regardless of motivation fluctuations
Treatment Transition SupportSimplifies progression through Residential Treatment, IOP, and Addiction Aftercare Services with consistent monthly dosing

 

Read More Show Less
Sublocade Success

How We Optimize Sublocade Outcomes

Effective Sublocade treatment requires more than monthly injections – proper implementation and integrated support determine success.

Medical Excellence

Our Sublocade program maintains the highest standards of care:

  • REMS-certified providers authorized to prescribe and administer Sublocade
  • Experience with buprenorphine therapy and extended-release formulations
  • Proper storage and handling of medication
  • Injection technique training, ensuring correct administration
  • Management of injection site reactions and other concerns

Integrated Treatment

Sublocade works optimally when combined with comprehensive addiction services:

  • Individual Therapy exploring underlying issues and building recovery skills
  • Group Therapy providing peer connection and mutual support
  • Cognitive Behavioral Therapy (CBT) addressing thought patterns driving use
  • Trauma Therapy processing experiences underlying addiction when appropriate
  • Family Therapy rebuilding relationships and establishing support structures

Continuity Planning

We ensure seamless Sublocade access across treatment phases:

  • Injection scheduling coordinated with treatment level transitions
  • No gaps in medication coverage when stepping down from residential care
  • Continued access through IOP and aftercare programming
  • Long-term maintenance planning for sustained recovery
  • Transition support if moving to community providers
Read More Show Less

Medical Excellence

Our Sublocade program maintains the highest standards of care:

  • REMS-certified providers authorized to prescribe and administer Sublocade
  • Experience with buprenorphine therapy and extended-release formulations
  • Proper storage and handling of medication
  • Injection technique training, ensuring correct administration
  • Management of injection site reactions and other concerns

Integrated Treatment

Sublocade works optimally when combined with comprehensive addiction services:

  • Individual Therapy exploring underlying issues and building recovery skills
  • Group Therapy providing peer connection and mutual support
  • Cognitive Behavioral Therapy (CBT) addressing thought patterns driving use
  • Trauma Therapy processing experiences underlying addiction when appropriate
  • Family Therapy rebuilding relationships and establishing support structures

Continuity Planning

We ensure seamless Sublocade access across treatment phases:

  • Injection scheduling coordinated with treatment level transitions
  • No gaps in medication coverage when stepping down from residential care
  • Continued access through IOP and aftercare programming
  • Long-term maintenance planning for sustained recovery
  • Transition support if moving to community providers
Sublocade Across Levels of Care

Sublocade Across Levels of Care

Sublocade treatment integrates with all levels of care, providing consistent medication support throughout the recovery journey.

In Residential Treatment

Residential Treatment provides optimal conditions for Sublocade initiation or continuation:

  • Stabilization on daily buprenorphine if not already established
  • Transition to Sublocade once stability confirmed
  • Medical monitoring during initial injections
  • Integration with intensive daily therapeutic programming
  • Discharge planning ensuring continued injection access

In Intensive Outpatient Programs

Intensive Outpatient Program (IOP) and Virtual IOP continue Sublocade seamlessly:

  • Monthly injections administered at our facility
  • Appointments coordinated with therapy sessions
  • Ongoing assessment of treatment response
  • Flexibility in scheduling around work and family obligations
  • Continued integration with clinical programming

In Aftercare

Addiction Aftercare Services maintain long-term Sublocade support:

  • Continued monthly injections at our facility
  • Option to transfer to community provider if preferred
  • Ongoing recovery monitoring and support
  • Evaluation of long-term medication needs
  • Discussion of potential tapering when clinically appropriate

Transitioning From Other Settings

Individuals arriving from other treatment settings receive coordinated Sublocade care:

  • Verification of current buprenorphine stability
  • Continuation of Sublocade without interruption
  • Medical records transfer and review
  • Integration into our treatment programming
  • Establishment of ongoing injection schedule
The Science Behind Sublocade

The Science Behind Sublocade

Our Sublocade protocols are supported by clinical research demonstrating effectiveness, safety, and advantages over daily buprenorphine formulations.

Key Research Findings

Treatment success
Pivotal trials showed 30% of Sublocade patients achieved treatment success (abstinence with no evidence of illicit opioid use) compared to only 2% receiving placebo (Haight et al., 2019)
Craving reduction
Sublocade produced sustained suppression of opioid cravings throughout the monthly dosing interval, with benefits maintained at consistent levels (Lofwall et al., 2018)
Withdrawal prevention
Extended-release buprenorphine effectively prevented withdrawal symptoms continuously between monthly doses, eliminating daily dosing concerns (Ling et al., 2020)
Treatment retention
Monthly dosing improved treatment retention compared to historical data on daily buprenorphine, likely due to reduced adherence burden (Haight et al., 2019)
Steady levels
Pharmacokinetic studies confirm Sublocade maintains consistent plasma buprenorphine concentrations throughout the monthly interval, avoiding peaks and troughs (Nasser et al., 2014)
We continuously update our protocols as new research emerges, ensuring you benefit from the latest advances in addiction medicine.

Key Research Findings

  • Treatment success: Pivotal trials showed 30% of Sublocade patients achieved treatment success (abstinence with no evidence of illicit opioid use) compared to only 2% receiving placebo (Haight et al., 2019)
  • Craving reduction: Sublocade produced sustained suppression of opioid cravings throughout the monthly dosing interval, with benefits maintained at consistent levels (Lofwall et al., 2018)
  • Withdrawal prevention: Extended-release buprenorphine effectively prevented withdrawal symptoms continuously between monthly doses, eliminating daily dosing concerns (Ling et al., 2020)
  • Treatment retention: Monthly dosing improved treatment retention compared to historical data on daily buprenorphine, likely due to reduced adherence burden (Haight et al., 2019)
  • Steady levels: Pharmacokinetic studies confirm Sublocade maintains consistent plasma buprenorphine concentrations throughout the monthly interval, avoiding peaks and troughs (Nasser et al., 2014)

We continuously update our protocols as new research emerges, ensuring you benefit from the latest advances in addiction medicine.

Read More Show Less
Why Choose Us

Why Choose Addiction Recovery Center for Sublocade Treatment

Sublocade Treatment Near Me

Sublocade Treatment Near Me

Searching for monthly buprenorphine injections for opioid addiction in Southern California? Addiction Recovery Center provides comprehensive Sublocade treatment in Orange County, offering extended-release buprenorphine combined with evidence-based therapy for adults throughout the region. Our facility serves residents of Irvine, Newport Beach, Costa Mesa, Huntington Beach, Anaheim, Santa Ana, and surrounding Orange County communities, as well as clients from Los Angeles, Riverside, San Bernardino, and throughout Southern California. Explore our Facility Virtual Tour to see our treatment environment.
FAQs

Sublocade Treatment FAQs

Do I need to be on daily buprenorphine before starting Sublocade?

Yes, Sublocade is approved for individuals who have initiated treatment with a transmucosal buprenorphine product (like Suboxone) and have been on a stable dose for at least 7 days. This ensures your body tolerates buprenorphine well and allows dose optimization before transitioning to monthly injections.

What does the Sublocade injection feel like?

Sublocade is a subcutaneous injection in the abdominal area. You may feel brief discomfort during injection and mild soreness afterward. A small lump or bump may form at the injection site – this is normal and is where the medication slowly releases over the month. Most patients tolerate injections well with minimal discomfort.

How is Sublocade different from Suboxone?

Both contain buprenorphine, but delivery differs significantly. Suboxone is a daily sublingual film or tablet you take yourself. Sublocade is a monthly injection administered by a healthcare provider. Sublocade provides steadier medication levels and eliminates daily dosing, while Suboxone offers more flexible dose adjustments and can be initiated during active withdrawal.

Can I switch back to daily Suboxone if Sublocade does not work for me?

Yes, transitioning back to daily buprenorphine is possible if Sublocade is not the right fit. Our medical team helps manage any transitions between formulations based on your needs and preferences. The goal is to find the medication approach that best supports your recovery.

What happens if I miss my monthly Sublocade appointment?

Sublocade continues releasing medication for several weeks, providing some buffer if you cannot make your exact appointment date. However, maintaining the monthly schedule is important for optimal effectiveness. If you must reschedule, contact us as soon as possible to arrange an alternative appointment time.

Does insurance cover Sublocade?

Most insurance plans cover Sublocade for opioid addiction treatment. The medication can be expensive without insurance, but coverage typically reduces costs significantly. Prior authorization may be required. Our admissions team verifies your specific benefits and assists with authorization before treatment begins. Visit our Verify Insurance Coverage page for more information.
CONTACT US

Steady Medication, Steady Progress

Sublocade transforms buprenorphine treatment from a daily requirement into a monthly appointment. This shift removes the constant reminder of medication dependence, eliminates adherence challenges, and provides consistent relief from cravings throughout each month. For those already benefiting from buprenorphine therapy, Sublocade offers a meaningful upgrade that simplifies recovery.

If you are currently stable on daily buprenorphine and ready to transition to monthly injections, or if you are new to MAT and interested in working toward Sublocade, our medical team is ready to evaluate your situation and develop an appropriate plan.

Contact Addiction Recovery Center at (866) 502-4344 or visit our Contact Us page for a free, confidential assessment to begin your journey toward recovery and renewed hope.

Read More Show Less
Seraphinite AcceleratorOptimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.